PLx Pharma Inc.·4

Nov 20, 7:43 PM ET

O'Connor Rita M 4

4 · PLx Pharma Inc. · Filed Nov 20, 2020

Insider Transaction Report

Form 4
Period: 2020-11-18
O'Connor Rita M
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-11-18+174,000174,000 total
    Exercise: $5.15Exp: 2030-11-18Common Stock (174,000 underlying)
Footnotes (2)
  • [F1]Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan.
  • [F2]These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.

Documents

1 file
  • 4
    form411577002oco_11202020.xmlPrimary

    OWNERSHIP DOCUMENT